IDEAL is important for research funding bodies who may receive applications to support the development of innovative interventional treatments.

Understanding the need for different types of study at different, identifiable points on the development pathway will help funding bodies consider supporting different types of study, particularly at the early stages of a new innovation.

It may also help bodies develop integrated funding schemes to support promising innovations through the various development stages culminating in definitive randomised trials.